For example, PXN, which is known as an oncogene in prostate cancer [15], has higher expression in the ERG and SPOP subtypes of prostate cancer, as compared to normal cells, and lower expression in ETV1 and ETV4 subtypes of prostate cancer, as compared to normal cells (Figure S1b). This evidence concerns the gene PXN and prostate carcinoma.